Laboratorio Reig Jofre, S.A. (LON:0RB1)

Market Cap	210.48M
Revenue (ttm)	288.76M
Net Income (ttm)	5.47M
Shares Out	n/a
EPS (ttm)	0.07
PE Ratio	38.49
Forward PE	19.30
Dividend	0.03 (1.11%)
Ex-Dividend Date	May 15, 2025

Volume	150
Average Volume	867
Open	2.920
Previous Close	2.960
Day's Range	2.920 - 2.920
52-Week Range	2.500 - 3.380
Beta	0.92
RSI	43.51
Earnings Date	Nov 5, 2025

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements und...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1929
• Employees: 1,437
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RB1

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 341.37 million, an increase of 7.36% compared to the previous year's 317.95 million. Earnings were 10.38 million, an increase of 10.36%.

Financial numbers in EUR